Search results
Alnylam Pharma Shares Surge 30% After Rare Heart Disease Drug Succeeds
Forbes· 18 hours agoShares of Alnylam Pharmaceuticals rose by over 32%, the company’s largest single-day gain in nearly...
Fixed-Ratio Insulin Combinations May Reduce Side Effects
Medscape· 18 hours agoUsing fixed-ratio insulin combinations (FRC) can reduce side effects such as nausea in treating...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 3 days agoNovavax shares aren't forming a chart pattern. The Sanofi deal is a positive for Novavax and could...
Izokibep Enthesitis Benefit Lacking in Phase 2b/3 PsA Trial
Medscape· 6 days agoThe primary efficacy endpoint was met, but the novel small molecule therapeutic did not reduce...
Feds try to delay release of non-public COVID vaccine safety data until at least 2026
Just the News· 5 days agoDistrict Judge Reggie Walton this week to issue an 18-month stay that keeps them from having to...
Gateway - Quartz
Quartz· 7 days agoModerna stock rose after new data suggested that its experimental vaccine could be used to treat a variety of cancers. The American Society of Health-System Pharmacists said the number of ongoing ...
ADA Scientific Sessions 2024 Go Beyond Glucose and Obesity
Medscape· 6 days agoScientific Sessions committee chair Alice Cheng, MD, told Medscape Medical News, "What we're going...
New JAK 1 Inhibitor Proves Promising in Phase 3 RA Trial
Medscape· 6 days ago"This is the first highly selective JAK inhibitor originally developed, and a phase 3 clinical trial...
Three’s a trend. Citi is the latest to bump S&P 500 target, but it sees opportunistic pullbacks...
MarketWatch via Yahoo Finance· 6 days agoThe emailed version will be sent out at about 7:30 a.m. Eastern. Check out On Watch by MarketWatch,...
Why Wall Street Is Chasing Ozempic Wannabes
The Wall Street Journal· 4 days agoThe Ozempic-driven fortunes being minted stand in contrast to the rest of the industry’s troubles. Companies such as Bristol-Myers Squibb Pfizer Johnson...
